TheProfitWatch

DYN - Dyne Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
15.41 1.2 (7.79%) --- --- 0.08 (0.48%) 0.19 (1.23%) 0.97 (6.23%) 0.01 (0.06%) 0.01 (0.06%)

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.97
Diluted EPS:
-0.97
Basic P/E:
-17.1237
Diluted P/E:
-17.1237
RSI(14) 1m:
100.0
VWAP:
16.61
RVol:
1.1491

Events

Period Kind Movement Occurred At
10m Price increase 10m 16.07 +0.49 (+3.11%) Oct 15 09:38
1m Price increase 1m 15.85 +0.16 (+1.05%) Oct 15 09:33

Related News